The authors relay the outcome of a two-day workshop that brought together regulators and generic-drug industry representatives.
Michael C. Olson
Advertisement
Michael C. Olson is a chemist at the Office of Pharmaceutical Science at FDA.
Articles by Michael C. Olson
Advertisement
Latest Updated Articles
Quality by Design for Generic DrugsPublished: October 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: Instrumentation Innovation for Bioanalysis
2
Using A Streamlined Workflow to Identify Particulates in Biologic Drugs
3
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
4
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
5
